Showing all published months. Partner preview tables include up to 5 countries.
USD value by month, all available partner countries combined
Free partner preview shows up to 5 countries.
Total value across the selected data period
| Partner | Value | Share |
|---|---|---|
| India | $26.4M | 18.7% |
| Vietnam | $18.3M | 13.0% |
| Pakistan | $11M | 7.8% |
| Egypt | $10.1M | 7.2% |
| Thailand | $5.9M | 4.2% |
Availability is confirmed when the API response loads.
| Partner | Value | Share |
|---|---|---|
| India | $701K | 38.2% |
| Argentina | $139.8K | 7.6% |
| Mexico | $128.8K | 7.0% |
| Taiwan | $126.3K | 6.9% |
| UAE | $122.8K | 6.7% |
| Year | Export value |
|---|---|
| 2021 | $19.5M |
| 2022 | $16.4M |
| 2023 | $25M |
| 2024 | $27.2M |
| 2025 | $28.7M |
| 2026 | $24.2M |
Public data shows up to 5 partner countries for this exact eight-digit customs code. Request all available partner-month rows in CSV.
HS 30032012 is also written 3003.20.12. Values are in USD; the public series does not report tonnes or kg. Product scope: Institutional or bulk-quantity medicines utilizing ceftazidime as the active antibiotic component are traded without measured retail packaging. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments of ceftazidime, neither in measured doses nor in retail packings (HS 30032012) Export Data." https://chinadata.live/china-trade/hs8/30032012/
HS 30032012 is also written 3003.20.12. Values are in USD; the public series does not report tonnes or kg. Product scope: Institutional or bulk-quantity medicines utilizing ceftazidime as the active antibiotic component are traded without measured retail packaging. The public page shows monthly export partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.
Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.
China Data Portal. "China Medicaments of ceftazidime, neither in measured doses nor in retail packings (HS 30032012) Export Data." https://chinadata.live/china-trade/hs8/30032012/
China exported $33.0M of medicaments of ceftazidime, neither in measured doses nor in retail packings in the twelve months to August 2026, averaging $2.8M per month, based on official China customs statistics (HS 30032012).
Institutional or bulk-quantity medicines utilizing ceftazidime as the active antibiotic component are traded without measured retail packaging.
India, Vietnam and Pakistan together account for 40% of the published total, out of 24 trading partners on record.
Annual exports grew by 48% between 2021 and 2025, from $19.5M to $28.7M.
Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.